Peptide Evaluation Framework

Peter Attia presents a framework for evaluating peptides, stressing the necessity of clear mechanisms, evidence of benefits, and risk assessments. He warns that many marketed peptides lack scientific support and advocates for a critical approach to their use.

AI-generated summary — may contain errors. How it works